fda glp-1 compounding enforcement news october 2025 Last month, the issued 25 warning letters to telehealth companies over what it called false or misleading claims about compounded medications Novo pressures GLP-1 compounders as

The batch of the ARPE-19 cells used in this study was validated using short tandem repeat (STR) analysis by Cobioer Biosciences (Nanjing, China)

Potential for longer healthspan: Because GLP-1 drugs can reduce risk factors for chronic diseases (like diabetes, heart disease, and possibly neurodegenerative diseases), they could help people stay healthier for longer as they age

No strict diet is required, but eating smaller, balanced meals helps maximize your results

Novo Nordisk plans to present details of its study, called ORION, at the Obesity Medicine Associations annual Obesity Medicine 2026 conference, set for April 10-12 in San Diego